5-Amino-1MQ
C10H11N2
Small molecule NNMT inhibitor supporting fat metabolism.
Capsule
View Research →
Metabolic
Peptides regulating metabolism, weight, and energy balance.
24 peptides in this category
ACE-031
C122H227N42O22
Fusion protein activin receptor IIB antagonist for muscle and metabolism.
Injectable
View Research →
AICAR
C9H15N4O8P
AMPK activator mimicking exercise effects on metabolism.
Injectable
View Research →
AOD-9604
C78H123N23O23S2
HGH fragment with fat-burning properties and no anabolic effects.
Injectable
View Research →
Cagrilintide
C194H312N54O59S2
Long-acting amylin analogue studied for weight management.
Injectable
View Research →
DADA
C8H17Cl2NO2
Adipokine-derived metabolic peptide.
Injectable
View Research →
DP-IV Inhibitor
C18H22FN3O2
Dipeptidyl peptidase-4 inhibitor enhancing GLP-1 activity.
Capsule
View Research →
GHRP-2
C45H55N9O6
Growth hormone releasing peptide-2 stimulating GH secretion.
Injectable
View Research →
GHRP-6
C46H56N12O6
Growth hormone releasing peptide-6 stimulating GH and appetite.
Injectable
View Research →
GIP
C178H294N56O57S
Gastric inhibitory polypeptide regulating insulin and fat storage.
Injectable
View Research →
GLP-1
C149H226N40O45
Glucagon-like peptide-1 regulating insulin and appetite.
Injectable
View Research →
GLP-2
C165H254N44O55S
Glucagon-like peptide-2 supporting intestinal health and nutrient absorption.
Injectable
View Research →
Glucagon
C153H225N43O49S
Pancreatic hormone raising blood glucose and stimulating lipolysis.
Injectable
View Research →
Insulin
C256H381N65O77S6
Pancreatic hormone regulating blood glucose levels.
Injectable
View Research →
Orexin-A
C152H243N47O44S4
Neuropeptide regulating wakefulness and energy homeostasis.
Injectable
View Research →
Oxytocin
C43H66N12O12S2
Social bonding peptide with metabolic and mood-regulatory effects.
Injectable
View Research →
PEG-MGF
C121H200N42O39
PEGylated Mechano Growth Factor with extended activity.
Injectable
View Research →
PGC-1 Alpha
Variable
Transcriptional coactivator regulating energy metabolism.
Injectable
View Research →
Retatrutide
C223H343F3N46O70
Triple agonist (GLP-1/GIP/glucagon) for exceptional weight loss — the most potent investigational obesity drug to date.
Injectable
View Research →
Semaglutide
C187H291N45O59
GLP-1 receptor agonist for type 2 diabetes and weight management (Ozempic/Wegovy).
Injectable
View Research →
Tesamorelin
C221H366N72O67S
GHRH analogue reducing visceral fat in HIV-related lipodystrophy.
Injectable
View Research →
Tirzepatide
C225H348N48O68
Dual GIP and GLP-1 receptor agonist for type 2 diabetes and obesity.
Injectable
View Research →
Uroguanylin
C61H101N17O25S4
Gut hormone regulating electrolyte balance and appetite.
Injectable
View Research →
VIP
C147H237N43O43S
Vasoactive intestinal peptide with metabolic and neuroprotective effects.
Injectable
View Research →